Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Current Leases: 2019

Historic Current Leases for Akebia Therapeutics (AKBA) over the last 1 years, with Dec 2019 value amounting to $5.0 million.

  • Akebia Therapeutics' Current Leases fell 83.72% to $5.1 million in Q1 2020 from the same period last year, while for Mar 2020 it was $5.1 million, marking a year-over-year decrease of 83.72%. This contributed to the annual value of $5.0 million for FY2019, which is N/A change from last year.
  • Akebia Therapeutics' Current Leases amounted to $5.0 million in FY2019.
  • In the past 5 years, Akebia Therapeutics' Current Leases registered a high of $5.0 million during FY2019, and its lowest value of $5.0 million during FY2019.
  • Over the past 1 years, Akebia Therapeutics' median Current Leases value was $5.0 million (recorded in 2019), while the average stood at $5.0 million.